| Skyview Care And Rehab At Bridgeport | |
| 505 O Street, Bridgeport, Nebraska 69336 | |
| (308) 262-0725 | |
| Name | Skyview Care And Rehab At Bridgeport |
|---|---|
| Location | 505 O Street, Bridgeport, Nebraska |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 44 |
| Occupancy Rate | 97.5% |
| Medicare ID (CCN) | 285224 |
| Legal Business Name | Senex Foundation Of Nebraska Inc |
| Ownership Type | For Profit - Corporation |
| NPI Number | 1194217497 |
| Organization Name | SENEX FOUNDATION OF NEBRASKA, INC |
| Doing Business As | SKYVIEW CARE AND REHAB AT BRIDGEPORT |
| Address | 505 O St, Bridgeport, NE 69336 |
| Phone Number | 720-929-0086 |
News Archive
Rockwell Medical, a fully-integrated biopharmaceutical company offering innovative products and services targeting end-stage renal disease (ESRD), chronic kidney disease (CKD) and iron deficiency anemia, reported third quarter 2010 results today.
Opening blocked arteries, trying to keep heart attack victims alive, fixing defective heart valves, and treating other heart ailments cost $78 billion in 2006 - roughly 8 percent of the more than $1 trillion spent on all medical care for the community population, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.
It is well known that socioeconomic factors such as poverty and low education play a role in health, but new research released today at the American Public Health Association's 140th Annual Meeting in San Francisco, Calif., shows this association is also seen in biomarkers of the blood.
Dana Wm. Ryan, President, CEO and Chairman of the Board of RyMed Technologies, Inc., today responded to a mixed verdict in a patent infringement case concerning RyMed's InVision-Plus® with Neutral Advantage™ technology IV connector.
› Verified 1 days ago
| NPI Number | 1619314325 |
| Organization Name | SENEX FOUNDATION OF NEBRASKA, INC |
| Doing Business As | SKYVIEW CARE AND REHAB AT BRIDGEPORT |
| Address | 505 O St, Bridgeport, NE 69336 |
| Phone Number | 720-929-0086 |
News Archive
Rockwell Medical, a fully-integrated biopharmaceutical company offering innovative products and services targeting end-stage renal disease (ESRD), chronic kidney disease (CKD) and iron deficiency anemia, reported third quarter 2010 results today.
Opening blocked arteries, trying to keep heart attack victims alive, fixing defective heart valves, and treating other heart ailments cost $78 billion in 2006 - roughly 8 percent of the more than $1 trillion spent on all medical care for the community population, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.
It is well known that socioeconomic factors such as poverty and low education play a role in health, but new research released today at the American Public Health Association's 140th Annual Meeting in San Francisco, Calif., shows this association is also seen in biomarkers of the blood.
Dana Wm. Ryan, President, CEO and Chairman of the Board of RyMed Technologies, Inc., today responded to a mixed verdict in a patent infringement case concerning RyMed's InVision-Plus® with Neutral Advantage™ technology IV connector.
› Verified 1 days ago
| NPI Number | 1891803490 |
| Organization Name | HERITAGE OF BRIDGEPORT, INC |
| Doing Business As | HERITAGE OF BRIDGEPORT |
| Address | 505 O St, Bridgeport, NE 69336 |
| Phone Number | 308-262-0725 |
News Archive
Rockwell Medical, a fully-integrated biopharmaceutical company offering innovative products and services targeting end-stage renal disease (ESRD), chronic kidney disease (CKD) and iron deficiency anemia, reported third quarter 2010 results today.
Opening blocked arteries, trying to keep heart attack victims alive, fixing defective heart valves, and treating other heart ailments cost $78 billion in 2006 - roughly 8 percent of the more than $1 trillion spent on all medical care for the community population, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.
It is well known that socioeconomic factors such as poverty and low education play a role in health, but new research released today at the American Public Health Association's 140th Annual Meeting in San Francisco, Calif., shows this association is also seen in biomarkers of the blood.
Dana Wm. Ryan, President, CEO and Chairman of the Board of RyMed Technologies, Inc., today responded to a mixed verdict in a patent infringement case concerning RyMed's InVision-Plus® with Neutral Advantage™ technology IV connector.
› Verified 1 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Rockwell Medical, a fully-integrated biopharmaceutical company offering innovative products and services targeting end-stage renal disease (ESRD), chronic kidney disease (CKD) and iron deficiency anemia, reported third quarter 2010 results today.
Opening blocked arteries, trying to keep heart attack victims alive, fixing defective heart valves, and treating other heart ailments cost $78 billion in 2006 - roughly 8 percent of the more than $1 trillion spent on all medical care for the community population, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.
It is well known that socioeconomic factors such as poverty and low education play a role in health, but new research released today at the American Public Health Association's 140th Annual Meeting in San Francisco, Calif., shows this association is also seen in biomarkers of the blood.
Dana Wm. Ryan, President, CEO and Chairman of the Board of RyMed Technologies, Inc., today responded to a mixed verdict in a patent infringement case concerning RyMed's InVision-Plus® with Neutral Advantage™ technology IV connector.
› Verified 1 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 1 |
| Total Number of Penalties | 1 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 18.57 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 11.29 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 33.77 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 4.12 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 2.4 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 1.44 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 2.11 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 84.51 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 19.71 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 63.64 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 0 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 27.17 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 15.6 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 1.41 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 94.83 | 95.98 |